|
1
|
Myasoedova E, Crowson CS, Kremers HM,
Therneau TM and Gabriel SE: Is the incidence of rheumatoid
arthritis rising?: Results from Olmsted County, Minnesota
1955-2007. Arthritis Rheum. 62:1576–1582. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Silman AJ and Pearson JE: Epidemiology and
genetics of rheumatoid arthritis. Arthritis Res. 4(Suppl 3):
S265–S272. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
3
|
Heidari B: Rheumatoid Arthritis: Early
diagnosis and treatment outcomes. Caspian J Intern Med. 2:161–170.
2011.PubMed/NCBI
|
|
4
|
Cojocaru M, Cojocaru IM, Silosi I, Vrabie
CD and Tanasescu R: Extra-articular manifestations in rheumatoid
arthritis. Maedica (Buchar). 5:286–291. 2010.
|
|
5
|
Guo Q, Wang Y, Xu D, Nossent J, Pavlos NJ
and Xu J: Rheumatoid arthritis: Pathological mechanisms and modern
pharmacologic therapies. Bone Res. 6:152018. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Suurmond J, Zou YR, Kim SJ and Diamond B:
Therapeutics to block autoantibody initiation and propagation in
systemic lupus erythematosus and rheumatoid arthritis. Sci Transl
Med. 7:280ps2852015. View Article : Google Scholar
|
|
7
|
Derksen VFAM, Huizinga TWJ and van der
Woude D: The role of autoantibodies in the pathophysiology of
rheumatoid arthritis. Semin Immunopathol. 39:437–446. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Bugatti S, Manzo A, Montecucco C and
Caporali R: The clinical value of autoantibodies in rheumatoid
arthritis. Front Med (Lausanne). 5:3392018. View Article : Google Scholar
|
|
9
|
Bingham CO III: The pathogenesis of
rheumatoid arthritis: Pivotal cytokines involved in bone
degradation and inflammation. J Rheumatol Suppl. 65:3–9.
2002.PubMed/NCBI
|
|
10
|
Choy E: Understanding the dynamics:
Pathways involved in the pathogenesis of rheumatoid arthritis.
Rheumatology (Oxford). 51(Suppl 5): pp. v3–v11. 2012, View Article : Google Scholar
|
|
11
|
Kinne RW, Stuhlmüller B and Burmester GR:
Cells of the synovium in rheumatoid arthritis. Macrophages
Arthritis Res Ther. 9:2242007. View
Article : Google Scholar
|
|
12
|
Ma Y and Pope RM: The role of macrophages
in rheumatoid arthritis. Curr Pharm Des. 11:569–580. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Pablos Álvarez JL: Interleukin 6 in the
physiopathology of rheumatoid arthritis. Reumatol Clin. 5:34–39.
2009.In Spanish. View Article : Google Scholar
|
|
14
|
Blanchard F, Duplomb L, Baud'huin M and
Brounais B: The dual role of IL-6-type cytokines on bone remodeling
and bone tumors. Cytokine Growth Factor Rev. 20:19–28. 2009.
View Article : Google Scholar
|
|
15
|
Kwan Tat S, Padrines M, Théoleyre S,
Heymann D and Fortun Y: IL-6, RANKL, TNF-alpha/IL-1: Interrelations
in bone resorption pathophysiology. Cytokine Growth Factor Rev.
15:49–60. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Weitzmann MN: The role of inflammatory
cytokines, the RANKL/OPG axis, and the immunoskeletal interface in
physiological bone turnover and osteoporosis. Scientifica (Cairo).
2013:1257052013.
|
|
17
|
Park JW, Ko SH, Kim CW, Jeoung BJ and Hong
CS: Identification and characterization of the major allergen of
the Humulus japonicus pollen. Clin Exp Allergy. 29:1080–1086. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Sung B, Chung JW, Bae HR, Choi JS, Kim CM
and Kim ND: Humulus japonicus extract exhibits antioxidative and
anti-aging effects via modulation of the AMPK-SIRT1 pathway. Exp
Ther Med. 9:1819–1826. 2015.In Korean. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Park SW, Woo CJ, Chung SK and Chung KT:
Antimicrobial and antioxidative activities of solvent fraction from
Humulus japonicas. Korean J Food Sci Technol. 26:464–470. 1994.
|
|
20
|
Lim H, Noh JR, Kim YH, Hwang JH, Kim KS,
Choi DH, Go MJ, Han SS, Oh WK and Lee CH: Anti-atherogenic effect
of Humulus japonicus in apolipoprotein E-deficient mice. Int J Mol
Med. 38:1101–1110. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Brand DD, Latham KA and Rosloniec EF:
Collagen-induced arthritis. Nat Protoc. 2:1269–1275. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Nandakumar KS, Bäcklund J, Vestberg M and
Holmdahl R: Collagen type II (CII)-specific antibodies induce
arthritis in the absence of T or B cells but the arthritis
progression is enhanced by CII-reactive T cells. Arthritis Res
Ther. 6:R544–R550. 2004. View
Article : Google Scholar : PubMed/NCBI
|
|
23
|
Brand DD, Kang AH and Rosloniec EF: The
mouse model of collagen-induced arthritis. Methods Mol Med.
102:295–312. 2004.PubMed/NCBI
|
|
24
|
Lee CH, Bae SJ and Kim M:
Mucosa-associated lymphoid tissue lymphoma translocation 1 as a
novel therapeutic target for rheumatoid arthritis. Sci Rep.
7:118892017. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Sun J, Jia Y, Li R, Guo J, Sun X, Liu Y,
Li Y, Yao H, Liu X, Zhao J and Li Z: Altered influenza virus
haemagglutinin (HA)-derived peptide is potent therapy for CIA by
inducing Th1 to Th2 shift. Cell Mol Immunol. 8:348–358. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Jhun JY, Yoon BY, Park MK, Oh HJ, Byun JK,
Lee SY, Min JK, Park SH, Kim HY and Cho ML: Obesity aggravates the
joint inflammation in a collagen-induced arthritis model through
deviation to Th17 differentiation. Exp Mol Med. 44:424–431. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
28
|
Laria A, Lurati A, Marrazza M, Mazzocchi
D, Re KA and Scarpellini M: The macrophages in rheumatic diseases.
J Inflamm Res. 9:1–11. 2016.PubMed/NCBI
|
|
29
|
Kinne RW, Bräuer R, Stuhlmüller B,
Palombo-Kinne E and Burmester GR: Macrophages in rheumatoid
arthritis. Arthritis Res. 2:189–202. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Fukui S, Iwamoto N, Takatani A, Igawa T,
Shimizu T, Umeda M, Nishino A, Horai Y, Hirai Y, Koga T, et al: M1
and M2 monocytes in rheumatoid arthritis: A contribution of
imbalance of M1/M2 monocytes to osteoclastogenesis. Front Immunol.
8:19582018. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Munder M, Eichmann K and Modolell M:
Alternative metabolic states in murine macrophages reflected by the
nitric oxide synthase/arginase balance: Competitive regulation by
CD4+ T cells correlates with Th1/Th2 phenotype. J Immunol.
160:5347–5354. 1998.PubMed/NCBI
|
|
32
|
Mukherjee P, Wu B, Mayton L, Kim SH,
Robbins PD and Wooley PH: TNF receptor gene therapy results in
suppression of IgG2a anticollagen antibody in collagen induced
arthritis. Ann Rheum Dis. 62:707–714. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Corry DB and Kheradmand F: Induction and
regulation of the IgE response. Nature. 402:B18–B23. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Srirangan S and Choy EH: The role of
interleukin 6 in the pathophysiology of rheumatoid arthritis. Ther
Adv Musculoskelet Dis. 2:247–256. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Oike T, Sato Y, Kobayashi T, Miyamoto K,
Nakamura S, Kaneko Y, Kobayashi S, Harato K, Saya H, Matsumoto M,
et al: Stat3 as a potential therapeutic target for rheumatoid
arthritis. Sci Rep. 7:109652017. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Rehman Q and Lane NE: Bone loss.
Therapeutic approaches for preventing bone loss in inflammatory
arthritis. Arthritis Res. 3:221–227. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Hwang SY, Jo MJ, Kim SC and Jee SY:
Anti-inflammaory effects of the MeOH extract of Humulus japonicus
in vivo. J Korean Orient Med Ophthalmol Otolaryngol Dermatol.
22:92–103. 2009.
|
|
38
|
Burrage PS, Mix KS and Brinckerhoff CE:
Matrix metalloproteinases: Role in arthritis. Front Biosci.
11:529–543. 2006. View
Article : Google Scholar
|
|
39
|
Lerner A, Neidhöfer S, Reuter S and
Matthias T: MMP3 is a reliable marker for disease activity,
radiological monitoring, disease outcome predictability, and
therapeutic response in rheumatoid arthritis. Best Pract Res Clin
Rheumatol. 32:550–562. 2018. View Article : Google Scholar
|
|
40
|
Rose BJ and Kooyman DL: A tale of two
joints: The role of matrix metalloproteases in cartilage biology.
Dis Markers. 2016:48950502016. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Amin AR, Attur M and Abramson SB: Nitric
oxide synthase and cyclooxygenases: Distribution, regulation, and
intervention in arthritis. Curr Opin Rheumatol. 11:202–209. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Wang Y, Han CC, Cui D, Li Y, Ma Y and Wei
W: Is macrophage polarization important in rheumatoid arthritis?
Int Immunopharmacol. 50:345–352. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Cope AP, Schulze-Koops H and Aringer M:
The central role of T cells in rheumatoid arthritis. Clin Exp
Rheumatol. 25:S4–S11. 2007.PubMed/NCBI
|
|
44
|
Kaplan C, Valdez JC, Chandrasekaran R,
Eibel H, Mikecz K, Glant TT and Finnegan A: Th1 and Th2 cytokines
regulate proteoglycan-specific autoantibody isotypes and arthritis.
Arthritis Res. 4:54–58. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
45
|
Aarvak T, Chabaud M, Thoen J, Miossec P
and Natvig JB: Changes in the Th1 or Th2 cytokine dominance in the
synovium of rheumatoid arthritis (RA): A kinetic study of the Th
subsets in one unusual RA patient. Rheumatology (Oxford).
39:513–522. 2000. View Article : Google Scholar
|
|
46
|
Yoshida Y and Tanaka T: Interleukin 6 and
rheumatoid arthritis. Biomed Res Int. 2014:6983132014. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Yoshitake F, Itoh S, Narita H, Ishihara K
and Ebisu S: Interleukin-6 directly inhibits osteoclast
differentiation by suppressing receptor activator of NF-kappaB
signaling pathways. J Biol Chem. 283:11535–11540. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Panagopoulos PK and Lambrou GI: Bone
erosions in rheumatoid arthritis: Recent developments in
pathogenesis and therapeutic implications. J Musculoskelet Neuronal
Interact. 18:304–319. 2018.PubMed/NCBI
|
|
49
|
Sato K and Takayanagi H: Osteoclasts,
rheumatoid arthritis, and osteoimmunology. Curr Opin Rheumatol.
18:419–426. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Schett G and Gravallese E: Bone erosion in
rheumatoid arthritis: Mechanisms, diagnosis and treatment. Nat Rev
Rheumatol. 8:656–664. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Jung SM, Kim KW, Yang CW, Park SH and Ju
JH: Cytokine-mediated bone destruction in rheumatoid arthritis. J
Immunol Res. 2014:2636252014. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Lieben L: Bone: The concept of
RANKL-independent osteoclastogenesis refuted. Nat Rev Rheumatol.
12:6232016. View Article : Google Scholar : PubMed/NCBI
|
